As our knowledge of Fluothane is still very incomplete we wish to avoid statements about its properties and behaviour which are too dogmatic, and to confine ourselves to what has been observed during the actual clinical administration of the drug in approximately 500 cases.
last as long. With the Cyprane inhaler at a constant setting, only eight to ten minutes' analgesia could be obtained, presumably because of cooling of the vapourizer. Recovery was not as prompt as after nitrous oxide-oxygen, and when this was used in conjunction with Fluoromar, there was difficulty in keeping the patient out of the second stage of antsthesia. This combination proved very good for dental extractions and in premedicated hospitalized patients, but when tried in 52 unselected outpatients excessive salivation and nausea and vomiting were troublesome. Fluoromar did not prove as satisfactory as methyl n-propyl ether or trichlorethylene for this purpose.
A comparison of the properties of Fluoromar and its effects in man with those of other volatile agents is made in Table III . This does not reveal any outstanding advantage over drugs already available in British anesthetic practice. Had it been completely noninflammable, it would have been very useful; and had it been less easy to produce apncea and hypotension, it might have been the drug of choice for the inexperienced or occasional anmsthetist. As it stands there does not seem any point in introducing the drug into this country.
The investigation was begun in the middle of 1956 when Johnstone had already been using Fluothane for several months. We therefore had the advantage of knowing a little of what might be expected after reading a preliminary report which he submitted to Imperial Chemical Industries Ltd. who developed (Raventos, 1956; Raventos and Suckling, 1956) and manufactured the drug. The method of administration which he was using was also known, and through the medium of Sir Robert Macintosh who visited Johnstone at work, we received much practical advice. It is therefore obvious that Johnstone's experience is greater than ours, and any credit which may be due for the introduction of this drug into anesthesia is his. On the other hand, if subsequent events prove that blame rather than credit is appropriate, we must accept our fair share in the knowledge that we may have furthered the popularity of this agent.
Fluothane is a clear, colourless, heavy liquid with a specific gravity of 1-86. It has a boiling point of 510 C., and thus volatilizes comparatively easily, giving off a vapour with a sweetish odour simnilar to that of chloroform. Chemically, it is a halogenated ethane which has the virtue of being non-inflammable and non-explosive.
F Br F-CC----Cl F H It has therefore aroused the interest of the Medical Research Council Committee on Non-Explosive Anesthetics who are independently carrying out an extensive investigation.
The first object was to administer Fluothane by the simplest means to determine the effectiveness of known concentrations of vapour, and in doing this to avoid, as far as possible, the influence of other anmsthetic drugs. Initially, therefore, we employed the open drop method of administration, and also an E.M.O. ether inhaler (Epstein and Macintosh, 1956) modified and calibrated for Fluothane. With the exception of volunteers and about 20 patients, all received some combination of premedicant drugs. In addition, the majority of our patients were induced with a preliminary injection of thiopentone.
It appeared that 1 % Fluothane vapour in air was the weakest concentration capable of producing unconsciousness in an unpremedicated healthy adult. Even the prolonged inhalation of 0 5% Fluothane in these circumstances failed to cause loss of consciousness, nor indeed, any worth-while degree of analgesia. Concentrations of 2% Fluothane in air produced satisfactory surgical anxesthesia in most cases, although the degree of relaxation obtained depended to a large extent on the respiratory efforts of the patient (if these were not. assisted) and, hence, the influence of other depressant drugs. Rarely was it necessary to exceed a concentration of 2%, although 3 % was employed on occasions in robust subjects or where extreme degrees of relaxation were necessary. Induction was usually rapid, smooth, and free from unpleasant subjective sensations for the patient. Coughing and breath holding were rare, and an excitement stage unusual. The preliminary injection of thiopentone seemed to reduce the incidence of restlessness and helped to provide a smoother induction. Thus, quite apart from considerations for the comfort of the patient, a "sleep dose" of thiopentone became routine before most administrations.
During the course of every anxsthetic we came to expect several characteristic features: flushing of the skin which became warm and dry; suffusion of the conjunctival vessels; and dilatation of the superficial veins of the limbs which became prominent. This occurred within a few minutes of starting the administration and was more marked than might have been expected with other forms of anmsthesia. The masseter muscles relaxed early and with depression of the pharyngeal reflexes an oral airway or a laryngoscope could be introduced.
At this time, stimulation of the cords would result in closing of the glottis, possibly a cough, but not laryngeal spasm.
There was a fall in blood pressure within the first five minutes, usually accompanied by a reduction in pulse-rate. It has been suggested that Fluothane is a sympathetic-ganglion blocking agent, and the almost typical fall in blood pressure, together with the general appearance of the patient would support this view, although this has not been proved pharmacologically. In a high proportion of cases there was a fall in the minute volume accompanied by a compensatory rise in the respiratory rate. But in some volunteers, very slow rates were seen. This appears to be an individual variation which is not predictable and for which we can offer no satisfactory explanation.
After stopping the administration, consciousness returned quickly unless pre-operative medication had been heavy. We were impressed by the speed with which volunteers recovered their mental alertness, although a physical sensation of lassitude persisted for several minutes. During this time, diplopia was noticed and, not uncommonly, a marked dryness of the mouth. On recovery, patients usually felt well and there was a minimum of nausea and vomiting. However, since there was no residual analgesia, the pain of an operation was soon felt and this effect was, of course, most marked in children who received a barbiturate for premedication. Not unnaturally this painful stimulation disturbs the patient and may cause restlessness. As soon as an analgesic was given, the restlessness ceased and emergence from an2esthesia became peaceful.
From this broad pattern of anesthesia under Fluothane, certain features demand further attention. EFFECT ON THE RESPIRATORY SYSTEM As a rule, the depth of respiration decreased and the rate increased during the course of an anaesthetic. This was apparent clinically, and was often sufficient to cause cyanosis unless respiration was assisted, or oxygen added to an inspired mixture of Fluothane and air. Measurements of minute volumes were made by allowing the inspired vapour to be drawn through a spirometer, and were found to be surprisingly small. In both volunteers and patients recordings were obtained of less than 2 litres per minute after only five minutes' inhalation of 1 % Fluothane in air. Such extreme degrees of depression were unusual, but it soon became obvious that an increase in the respiratory rate, even in the presence of an apparently adequate minute volume, could result in an insufficient tidal exchange.
Recently, we have attempted to reproduce Johnstone's technique of giving nitrous oxide, oxygen and Fluothane from a Boyle machine, but substituting the specially calibrated E.M.O. inhaler for the trilene bottle. The concentration of oxygen was never allowed to fall below 25 %, and no cyanosis was seen in patients who received this mixture. The pattern of depressed minute volume and increased respiratory rate still persisted, and, in both groups, the effect of premedication was obvious, and confirmed our earlier opinion (Bryce-Smith and O'Brien, 1956) that light premedication with atropine alone, or pethidine 50 mg. and atropine, is preferable to the more usual mixtures containing morphine or Omnopon (see Table I ). The response of the body to Fluothane vapour needs more careful study, and since it must be assumed that carbon dioxide retention is occurring under these respiratory conditions, a study of carbon dioxide levels is needed. 
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62%J Under Fluothane/air anmsthesia, respiration is usually smooth, quiet and regular. The vapour is not irritating to the respiratory tract and respiration can usually be controlled with the greatest of ease at light levels of anasthesia.
In experimental work on dogs, and in patients who received Fluothane/air only, periods of apnoea lasting for one to two minutes sometimes occurred during induction. These were never seen after induction with thiopentone, nor have they been apparent in patients who received the thiopentone, nitrous oxide, oxygen, and Fluothane mixture. This apnoea did not appear to be related to the concentration of vapour administered, and was not a response to a high concentration which might have caused laryngeal spasm. Inflation could still be performed with ease, and spontaneous respiration usually re-started after applying a painful stimulus.
EFFECT ON THE CARDIOVASCULAR SYSTEM The effect of Fluothane on the rate and rhythm of the heart has already been the subject of an intensive electrocardiographic study (Johnstone, 1956) . We have detected no cardiac arrhythmias during Fluothane anesthesia, but bradycardia occurred almost routinely. Even the administration of clinical doses of adrenaline (up to 0 5 mg.) caused no more than a temporary and brief increase in the pulse-rate.
Falls in blood pressure were common, and the degree of hypotension seemed to be related to the concentration of Fluothane vapour. In very few cases, however, were these falls of an alarming extent, and even when they did occur the general condition of the patient remained surprisingly good. Indeed, from the warm dry skin, and the strong pulse which could be felt at any of the classical points for palpation, it was hard to believe that any fall in blood pressure had occurred.
The blood pressure and pulse-rate tended to follow each other closely, and a rise in pulserate was nearly always followed by a rise in blood pressure. Thus we have come to place more reliance on atropine as the antidote to hypotension than on such agents as methyl amphetamine and ephedrine.
There was little to choose between the effect of Fluothane/air, and Fluothane, nitrous oxide, and oxygen on the blood pressure. The maximum and average falls of blood pressure in both groups were comparable, although the average fall with the higher concentrations of Fluothane (1 5-2O0%) was slightly greater in the Fluothane/air series (Table II) . All patients received thiopentone 0-25 gram for induction.
THE USE OF MUSCLE RELAXANTS wiTH FLUOTHANE
Succinylcholine chloride has been administered to 101 patients under Fluothane anmsthesia. The effects appeared to be identical to those seen when this muscle relaxant is used with other aneesthetic agents. 43 patients have received gallamine triethiodide and in some there have been slight falls in blood pressure. However, the extent of these falls has been no more than might be expected with Fluothane by itself. In at least half of the cases, there was, in fact, a slight rise in blood pressure, coinciding with the rise in pulse-rate which is characteristic of gallamine. d-tubocurarine chloride has been administered to 35 patients, but here the effect on the cardiovascular system tended to be more dramatic than with gallamine triethiodide. Falls in blood pressure were more common, and frequently more profound, but provided the concentration of Fluothane administered did not exceed 1 %, there has been no cause for serious alarm.
We are of the opinion that the non-depolarizing muscle relaxants should be used cautiously in conjunction with Fluothane. In particular, there is a risk of serious hypotension when dtubocurarine is administered in the presence of bradycardia. We must warn most strongly against the injudicious use of neostigmine. We believe that a preliminary injection of atropine should be made at least five minutes before the neostigmine is administered, and that the dose should be of the order of 1/75-1/50 grain. Neostigmine is best given in divided doses, never more than 1 mg. at a time, and the total dose not exceeding 2 5 mg. With less cautious dosage there may be a calamitous slowing of the pulse-rate.
These reactions to gallamine, d-tubocurarine, neostigmine and atropine are interesting, and when considered in relation to the appearance of the patient, the bradycardia, and the hypotension under Fluothane alone, suggest that this drug must exert some influence on the sympathetic nervous system. Since there is evidence that this does not occur at the ganglia, then it may well be that the action is more peripheral.
MISCELLANEOUS OBSERVATIONS Diplopia and dryness of the mouth have already been mentioned as not unusual features during the immediate recovery period. In addition, bouts of shivering lasting for five to ten minutes have been seen before consciousness has fully returned. The shivering appeared to be aggravated by any stimulation of the patient, but was seen less commonly when nitrous oxide, oxygen and Fluothane was used than Fluothane/air. Unfortunately, the administration of Fluothane demands a very careful control of the concentration of vapour. Thus, most existing anvsthetic apparatus in its present form is unsuitable for the administration of the drug. The difficulty is further increased by the knowledge that Fluothane, in the presence of moisture, can attack tin and aluminium. Considerable difficulty was experienced before the E.M.O. inhaler could be modified for use with Fluothane without undergoing corrosion and, in consequence, jamming of moving parts.
CONCLUSION
It is too early yet to pass judgment on Fluothane, but we believe that this agent merits a place in the anwsthetist's armamentarium. Non-inflammability, ease of administration, flexibility, smooth and rapid induction, quick recovery with a minimum of after-effects, and a bloodless surgical field, are advantages which cannot be dismissed lightly. On the other hand, depressed respiration, hypotension and bradycardia have sinister implications unless they are controllable and reversible. Further, they may be fatal unless recognized. Other disadvantages undoubtedly exist of which we have little or no knowledge, and until the investigations of the Committee of the Medical Research Council and others have been completed, the use of Fluothane should be limited and cautious.
While we think that Fluothane is an improvement on ethyl chloride either as a sole anesthetic or as an induction agent to ether, and by virtue of its flexibility could replace trichlorethylene in a nitrous oxide/oxygen sequence, to mention but two possibilities, we would be unwilling to make widespread recommendations for its use at present. It would be regrettable if such a promising drug acquired a bad reputation early on, due to ignorance of its properties and of the correct method of usage. Dr. M. Johnstone: I have now administered Fluothane to over 1,200 patients, using the technique already described (Johnstone, 1956) . With the 1 % (approx.) vapour concentration the induction, maintenance, and recovery from anmsthesia have been delightfully smooth in each patient. Spontaneous respiration has persisted in all patients and significant degrees of respiratory depression have been uncommon, presumably because I do not use morphine or its analogues as premedicants. Increased respiratory rates are common during Fluothane anesthesia but seldom of a degree requiring an adjustment of the technique.
Muscular relaxation has been adequate in all cases except in a proportion of the laparotomies; it has not yet been attempted to obtain further relaxation in the latter by increasing the Fluothane concentration. Roughly speaking, Fluothane 1-5% provides about 80% of the relaxation needed for an upper abdominal operation; the remaining 20% of the relaxation, required only during the initial exploration and the final closure of the peritoneal cavity, can be obtained with small doses of suxamethonium (30 mg. to 50 mg. intravenously). Longer-acting relaxants, particularly of the competitive type are not required and are probably contra-indicated for the reasons already mentioned (Johnstone, 1956) .
As far as I can tell, disturbances of cardiac rhythm are practically non-existent during Fluothane anesthesia in efficiently ventilated and adequately atropinized patients. Small hnmostatic doses of adrenaline (up to 20 c.c. of a 1/150,000 solution of adrenaline hydrochloride injected subcutaneously) have failed to cause any disturbance of cardiac rhythm in adults anesthetized with Fluothane. I have observed a multifocal ventricular tachycardia following the filling of a congested bladder with about 400 c.c. of a 1/100,000 solution of adrenaline hydrochloride during a cystoscopic examination of a patient under Fluothane anaesthesia; the arrhythmia was abolished immediately by the insufflation of ether vapour and recovery was uneventful. The hypotensive effect of Fluothane is minimal with the 1 % vapour concentration required for the maintenance of anaesthesia, provided atropine is given in adequate doses, the blood volume is maintained within reasonably normal limits, and postural influences are controlled.
Post-operative nausea and vomiting have been absent in over 95 % of my patients after Fluothane
Our impressions have been very favourable. It is easy and non-irritant to administer. Relaxation of the jaw occurs early, allowing insertion of the airway almost immediately. Relaxation is good and can be potentiated by the addition of any of the common relaxants. d-Tubocurarine chloride and Fluothane together generally cause hypotension, which is rarely severe. It appears to be safe with small quantities of adrenaline injected subcutaneously, but this requires further investigation.
Its worst feature is the often occurring, rapid, shallow respiration with marked falls in minute volume, but respiration can and should be assisted under these circumstances. It is very easy to control respiration completely.
Vomiting is mild following Fluothane, but it does occur. We feel that Fluothane deserves a prolonged clinical trial and may well prove the best agent to use in the presence of diathermy, particularly for short procedures requiring moderately deep anesthesia; and for operations where bleeding may be a great inconvenience to the surgeon, such as plastic operations, radical mastectomies, thyroidectomies and many E.N.T. operations.
Dr. H. J. Brennan: I have seen an alarming degree of bradycardia and hypotension in two healthy male adults premedicated with papaveretum and hyoscine-a condition immediately corrected by the intravenous injection of atropine sulphate. Hyoscine does not provide sufficient cardiac protection against Fluothane, and I regard adequate premedication with atropine as essential.
Dr. T. Cecil Gray: Fluothane appears to possess every property we consider bad in an anesthetic drug: Tachypncea combined with reduction in tidal volume, hypotension and sensitization of the heart to adrenaline are all extremely undesirable effects which the speakers have assured us are produced by this drug, and yet, to a man, they still regard it as a valuable agent! It is probable that the facts that it is non-explosive, non-inflammatory and produces rapid induction and recovery of anaesthesia will give it a small niche in anmsthetic practice but I find it difficult to conceive that it will replace any of the agents at present at our disposal.
The whole trend of anesthesia is to avoid the blunderbuss type of anmsthetic agent and to use drugs with as few side actions as possible, in order to achieve specific ends such as relaxation and hypotension. I hope that this is a principle that will not be easily abandoned.
Dr. L. Rendell-Baker: Though I agree that Fluothane opens a new and interesting avenue for research, I feel that the great frequency with which it produces .bradycardia and hypotension often combined with marked diminution of the patient's tidal exchange hardly marks it as an ideal anesthetic agent. The incidence of nausea and vomiting with Fluothane has certainly not been less than is commonly experienced following other agents such as trichloroethylene, for example. With some of the cases, vomiting has been troublesome.
